COVID-19 (RESP) Flashcards

1
Q

What is COVID-19?

A

A potentially severe acute respiratory infection caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How does COVID-19 transmission occur?

A

Primarily via respiratory droplets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How long is the average incubation period for COVID-19?

A

5 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the clinical features of COVID-19? (8)

A
  • fever
  • cough
  • dyspnoea
  • altered sense of smell/taste
  • headache
  • sore throat
  • nasal congestion/rhinorrhoea
  • fatigue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the first-line investigations for COVID-19? (4)

A
  • real-time reverse transcription polymerase chain reaction (RT-PCR) - isolated from a nasopharyngeal swab
  • rapid antigen test
  • pulse oximetry
  • CXR - if suspected pneumonia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are some differential diagnoses for COVID-19? (10)

A
  • community-acquired pneumonia
  • influenza
  • common cold
  • RSV virus in children <5
  • aspiration pneumonia (clinically indistinguishable, RT-PCR negative for SARS-CoV-2)
  • pneumocystis jirovecii pneumonia (immunocompromised)
  • Middle East respiratory syndrome (MERS)
  • avian influenza A (H7N9) - contact with infected birds
  • pulmonary TB (night sweats, weight loss)
  • febrile neutropenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the management plan for mild-to-moderate COVID-19? (3 + 3)

A
  • isolation + monitoring
  • symptom management and supportive care
  • antipyretic/analgesic
  • (antimicrobials)
  • (antiviral - nirmatrelvir/ritonavir, molnupiravir, remdesivir)
  • (monoclonal antibody)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the management plan for severe COVID-19? (4 + 5)

A
  • hospital admission
  • oxygen therapy
  • venous thromboembolism (VTE) prophylaxis
  • symptom management and prophylactic care
  • (antimicrobials)
  • (corticosteroid - dexamethasone)
  • (antiviral - remdesivir)
  • (IL-6 inhibitor - tocilizumab / sarilumab)
  • (JAK inhibitor - baricitinib)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the management plan for critical COVID-19? (10)

A
  • intensive/critical care unit admission
  • VTE prophylaxis
  • high-flow nasal oxygen / NIV
  • invasive mechanical ventilation
  • inhaled pulmonary vasodilator
  • ECMO
  • corticosteroid (dexamethasone)
  • antiviral (remdesivir)
  • IL-6 inhibitor - tocilizumab / sarilumab
  • JAK inhibitor - baricitinib
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are some complications of COVID-19? (10)

A
  • post-intensive care syndrome
  • thrombosis
  • cardiovascular complications
  • AKI
  • long COVID
  • myocarditis/pericarditis (post vaccination)
  • acute liver injury
  • neurological complications
  • cardiac arrest
  • pregnancy-related complications
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the leading cause of death from COVID-19?

A

Leading cause of death is respiratory failure from ARDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly